
Which patients might benefit the most from isatuximab-based combinations in the relapsed setting?
Multiple Myeloma Hub
00:00
Exploring the Efficacy of Isatuximab-Based Combinations in Relapsed Multiple Myeloma
Exploring the efficacy and benefits of Isatuximab in combination with carfilzomib and dexamethasone for treating multiple myeloma patients refractory to lenalidomide-based therapy, emphasizing the role of immunomodulatory agents in improving outcomes.
Transcript
Play full episode